[Our experience in the treatment of acute myeloblastic leukemia]. 1974

E Madon, and P G Baroncelli, and A Sacerdote, and P L Roberi, and L Cordero di Montezemolo

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

E Madon, and P G Baroncelli, and A Sacerdote, and P L Roberi, and L Cordero di Montezemolo
October 1996, Hematology and cell therapy,
E Madon, and P G Baroncelli, and A Sacerdote, and P L Roberi, and L Cordero di Montezemolo
March 1973, Therapeutique (La Semaine des hopitaux),
E Madon, and P G Baroncelli, and A Sacerdote, and P L Roberi, and L Cordero di Montezemolo
June 1993, Nouvelle revue francaise d'hematologie,
E Madon, and P G Baroncelli, and A Sacerdote, and P L Roberi, and L Cordero di Montezemolo
January 1973, Bibliotheca haematologica,
E Madon, and P G Baroncelli, and A Sacerdote, and P L Roberi, and L Cordero di Montezemolo
December 1976, Minerva pediatrica,
E Madon, and P G Baroncelli, and A Sacerdote, and P L Roberi, and L Cordero di Montezemolo
January 1979, Haematology and blood transfusion,
E Madon, and P G Baroncelli, and A Sacerdote, and P L Roberi, and L Cordero di Montezemolo
September 1955, Therapie der Gegenwart,
E Madon, and P G Baroncelli, and A Sacerdote, and P L Roberi, and L Cordero di Montezemolo
November 1977, Minerva pediatrica,
E Madon, and P G Baroncelli, and A Sacerdote, and P L Roberi, and L Cordero di Montezemolo
May 1977, La Nouvelle presse medicale,
E Madon, and P G Baroncelli, and A Sacerdote, and P L Roberi, and L Cordero di Montezemolo
December 1973, La Nouvelle presse medicale,
Copied contents to your clipboard!